BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.630
+0.396 (17.73%)
At close: Apr 28, 2026, 4:00 PM EDT
2.603
-0.027 (-1.05%)
After-hours: Apr 28, 2026, 6:02 PM EDT
BioLineRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1.18 | 28.94 | 4.8 | - | - | Upgrade
|
| Revenue Growth (YoY) | -95.92% | 502.92% | - | - | - | Upgrade
|
| Cost of Revenue | 0.23 | 9.26 | 3.69 | - | - | Upgrade
|
| Gross Profit | 0.95 | 19.68 | 1.11 | - | - | Upgrade
|
| Selling, General & Admin | 3.14 | 29.68 | 31.58 | 11.53 | 5.31 | Upgrade
|
| Research & Development | 8.09 | 9.15 | 12.52 | 17.63 | 19.47 | Upgrade
|
| Operating Expenses | 11.24 | 38.83 | 44.1 | 29.16 | 24.78 | Upgrade
|
| Operating Income | -10.29 | -19.15 | -42.99 | -29.16 | -24.78 | Upgrade
|
| Interest Expense | -1.25 | -9.07 | -2.14 | -1.79 | -0.98 | Upgrade
|
| Interest & Investment Income | 1.12 | 1.82 | 2.01 | 0.69 | 0.28 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.34 | 0.05 | 0.06 | -0.35 | 0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.05 | 18.39 | -10.84 | 5.64 | -1.85 | Upgrade
|
| EBT Excluding Unusual Items | -2.03 | -7.97 | -53.91 | -24.95 | -27.05 | Upgrade
|
| Asset Writedown | - | -1.26 | -6.7 | - | - | Upgrade
|
| Pretax Income | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 | Upgrade
|
| Earnings From Continuing Operations | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 | Upgrade
|
| Minority Interest in Earnings | 0.85 | - | - | - | - | Upgrade
|
| Net Income | -1.18 | -9.22 | -60.61 | -24.95 | -27.05 | Upgrade
|
| Net Income to Common | -1.18 | -9.22 | -60.61 | -24.95 | -27.05 | Upgrade
|
| Shares Outstanding (Basic) | 2,465 | 1,198 | 963 | 774 | 663 | Upgrade
|
| Shares Outstanding (Diluted) | 2,465 | 1,198 | 963 | 774 | 663 | Upgrade
|
| Shares Change (YoY) | 105.76% | 24.37% | 24.47% | 16.75% | 162.19% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.06 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.06 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | -8.1 | -43.93 | -22.72 | -26.37 | -23.67 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.04 | -0.02 | -0.03 | -0.04 | Upgrade
|
| Gross Margin | 80.51% | 67.99% | 23.08% | - | - | Upgrade
|
| Operating Margin | -871.78% | -66.18% | -895.65% | - | - | Upgrade
|
| Profit Margin | -99.58% | -31.86% | -1262.79% | - | - | Upgrade
|
| Free Cash Flow Margin | -686.36% | -151.78% | -473.42% | - | - | Upgrade
|
| EBITDA | -10.06 | -15.16 | -41.61 | -28.5 | -24.07 | Upgrade
|
| EBITDA Margin | - | -52.38% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.23 | 3.99 | 1.38 | 0.65 | 0.7 | Upgrade
|
| EBIT | -10.29 | -19.15 | -42.99 | -29.16 | -24.78 | Upgrade
|
| EBIT Margin | - | -66.18% | - | - | - | Upgrade
|
| Revenue as Reported | 1.18 | 28.94 | 4.8 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.